DK175218B1 - (1H-Azol-1-ylmethyl)substituerede benzotriazolderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende et benzotriazolderivat ifölge opfindelsen - Google Patents

(1H-Azol-1-ylmethyl)substituerede benzotriazolderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende et benzotriazolderivat ifölge opfindelsen Download PDF

Info

Publication number
DK175218B1
DK175218B1 DK198802952A DK295288A DK175218B1 DK 175218 B1 DK175218 B1 DK 175218B1 DK 198802952 A DK198802952 A DK 198802952A DK 295288 A DK295288 A DK 295288A DK 175218 B1 DK175218 B1 DK 175218B1
Authority
DK
Denmark
Prior art keywords
alkyl
formula
phenyl
parts
substituted
Prior art date
Application number
DK198802952A
Other languages
Danish (da)
English (en)
Other versions
DK295288A (da
DK295288D0 (da
Inventor
Alfons Herman Marg Raeymaekers
Eddy Jean Edgard Freyne
Marc Gaston Venet
Josephus Ludovicus Hube Gelder
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK295288D0 publication Critical patent/DK295288D0/da
Publication of DK295288A publication Critical patent/DK295288A/da
Application granted granted Critical
Publication of DK175218B1 publication Critical patent/DK175218B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK198802952A 1987-06-01 1988-05-31 (1H-Azol-1-ylmethyl)substituerede benzotriazolderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende et benzotriazolderivat ifölge opfindelsen DK175218B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5602187A 1987-06-01 1987-06-01
US5602187 1987-06-01

Publications (3)

Publication Number Publication Date
DK295288D0 DK295288D0 (da) 1988-05-31
DK295288A DK295288A (da) 1988-12-02
DK175218B1 true DK175218B1 (da) 2004-07-12

Family

ID=22001654

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802952A DK175218B1 (da) 1987-06-01 1988-05-31 (1H-Azol-1-ylmethyl)substituerede benzotriazolderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende et benzotriazolderivat ifölge opfindelsen

Country Status (24)

Country Link
EP (1) EP0293978B1 (lv)
JP (1) JPH0662612B2 (lv)
KR (1) KR970000952B1 (lv)
CN (1) CN1022184C (lv)
AU (1) AU603446B2 (lv)
BG (2) BG50278A3 (lv)
CA (1) CA1307271C (lv)
CY (1) CY1866A (lv)
DE (1) DE3884055T2 (lv)
DK (1) DK175218B1 (lv)
ES (1) ES2059490T3 (lv)
FI (1) FI90078C (lv)
HK (1) HK114795A (lv)
HU (2) HU201056B (lv)
IE (1) IE61823B1 (lv)
IL (1) IL86551A (lv)
LT (1) LT3950B (lv)
LV (1) LV10452B (lv)
NO (1) NO169900C (lv)
NZ (1) NZ224714A (lv)
PT (1) PT87623B (lv)
RU (1) RU1838308C (lv)
UA (1) UA11192A (lv)
ZA (1) ZA883861B (lv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
NZ236440A (en) * 1989-12-15 1993-07-27 Merck & Co Inc Reversal of sexual phenotype in poultry using an inhibitor of steroid biotransformation and/or aromatase inhibitor, poultry produced by this process
EP0445073A1 (de) * 1990-02-27 1991-09-04 Ciba-Geigy Ag Benzofurane
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (lv) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
TW210334B (lv) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE69230225T2 (de) 1991-09-02 2000-05-31 Yamanouchi Pharmaceutical Co., Ltd. Triazolylierte tertiäre aminverbindungen oder ihre salze
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
HUT72073A (en) * 1992-11-10 1996-03-28 Janssen Pharmaceutica Nv Process for preparing enantiomerically pure 6-[(4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl]-1-methyl-1h-benzotriazole
AU682947B2 (en) * 1994-05-27 1997-10-23 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
AU6821196A (en) * 1995-08-14 1997-03-12 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
KR100559816B1 (ko) * 1996-12-24 2006-03-10 쥬가이 세이야쿠 가부시키가이샤 Nos 저해작용을 가진 방향족 아민 유도체
WO2002000648A1 (fr) * 2000-06-28 2002-01-03 Ssp Co., Ltd. Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7521447B2 (en) * 2003-03-03 2009-04-21 Array Biopharma Inc. P38 inhibitors and methods of use thereof
CA2594477C (en) 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
EP1874304B1 (en) * 2005-04-29 2009-07-15 Janssen Pharmaceutica N.V. Benzotriazole derivatives as cannabinoid receptor antagonists
US7572807B2 (en) * 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
JP5238504B2 (ja) 2005-09-15 2013-07-17 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ イミダゾリル基で置換された新規なステロイド誘導体およびインダン−1−オン誘導体
SG175599A1 (en) 2006-01-31 2011-11-28 Array Biopharma Inc Kinase inhibitors and methods of use thereof
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (lv) * 1980-10-23 1984-07-13 Pfizer
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
DE3744589C1 (de) 1987-12-31 1988-12-29 Albrecht Josef Bohrfutter Nachspannendes Bohrfutter

Also Published As

Publication number Publication date
IL86551A0 (en) 1988-11-15
CN88103408A (zh) 1988-12-14
RU1838308C (ru) 1993-08-30
EP0293978A3 (en) 1990-06-13
AU1653788A (en) 1988-12-01
HK114795A (en) 1995-07-21
KR890000469A (ko) 1989-03-14
HU201056B (en) 1990-09-28
PT87623A (pt) 1988-06-01
FI882552A0 (fi) 1988-05-31
CN1022184C (zh) 1993-09-22
DE3884055T2 (de) 1994-01-27
LV10452A (lv) 1995-02-20
FI90078B (fi) 1993-09-15
CY1866A (en) 1988-05-26
NO882390D0 (no) 1988-05-31
BG60429B2 (bg) 1995-03-31
JPH0662612B2 (ja) 1994-08-17
BG50278A3 (en) 1992-06-15
NO169900B (no) 1992-05-11
PT87623B (pt) 1992-09-30
LTIP1625A (en) 1995-07-25
KR970000952B1 (ko) 1997-01-21
EP0293978A2 (en) 1988-12-07
NO882390L (no) 1988-12-02
ES2059490T3 (es) 1994-11-16
CA1307271C (en) 1992-09-08
DE3884055D1 (de) 1993-10-21
HU211482A9 (en) 1995-11-28
LV10452B (en) 1995-08-20
UA11192A (uk) 1996-12-25
JPS63316775A (ja) 1988-12-26
IE881640L (en) 1988-12-01
EP0293978B1 (en) 1993-09-15
FI90078C (fi) 1993-12-27
ZA883861B (en) 1990-01-31
FI882552A (fi) 1988-12-02
IL86551A (en) 1992-07-15
AU603446B2 (en) 1990-11-15
NZ224714A (en) 1990-03-27
HUT49132A (en) 1989-08-28
NO169900C (no) 1992-08-19
LT3950B (en) 1996-05-27
DK295288A (da) 1988-12-02
DK295288D0 (da) 1988-05-31
IE61823B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
DK175218B1 (da) (1H-Azol-1-ylmethyl)substituerede benzotriazolderivater, fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende et benzotriazolderivat ifölge opfindelsen
DK174728B1 (da) (1H-imidazol-1-ylmethyl)-substituerede benzimidazolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende derivaterne og anvendelse af derivaterne til fremstilling af lægemidler
US6683097B2 (en) Imidazole derivatives
US4859684A (en) (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
US5807857A (en) Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists
SK12442003A3 (sk) Pyrazolové deriváty na liečenie HIV
CZ292792B6 (cs) Chinoxalindiony, způsob a meziprodukty pro jejich výrobu, jejich použití a farmaceutické kompozice na jejich bázi
AU665569B2 (en) Triazolylated tertiary amine compound or salt thereof
US4943574A (en) (1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
KR19990028390A (ko) 트리아졸 항진균제
US5039677A (en) 6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US5441954A (en) (1h-azol-1-ylmethyl) substituted quinoline derivatives
KR960015004B1 (ko) (1h-이미다졸-1-일메틸)치환된 벤즈이미다졸 유도체의 제조방법
PH26050A (en) (1H-azol-1=ylmethyl)substituted benzotriazole derivatives
AU2002246043B2 (en) Imidazole derivatives
JP2500849B2 (ja) トリアゾリル置換3級アミノ化合物又はその塩
AU2002246043A1 (en) Imidazole derivatives

Legal Events

Date Code Title Description
PUP Patent expired